Can spontaneous adverse event reporting systems really be used to compare rates of adverse events between drugs? [35]

Anesthesia and Analgesia

Volumn 104, Issue 2, 2007, Pages 471-472

  Mertes, Paul M ^a   Guttormsen, Anne B ^b   Harboe, Torkel ^b   Johansson, S Gunnar O ^c   Florvaag, Erik ^b   Husum, Bent ^d   Garvey, Lene H ^d   Kroigaard, Morgens ^d   Gramstad, Lars ^e   Kvande, Kristin T ^e   Trechot, Philippe ^a   Malinovsky, Jean M ^f  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d Rigshospitalet   (Denmark)

^e Norwegian Medicines Agency   (Norway)

^f HÔPITAL MAISON BLANCHE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; CISATRACURIUM; ROCURONIUM; VECURONIUM;

ANAPHYLAXIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENERAL ANESTHESIA; HUMAN; INCIDENCE; INSTRUMENTATION; LETTER; PRIORITY JOURNAL; SKIN TEST; SPONTANEOUS ADVERSE EVENT REPORTING SYSTEM;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANAPHYLAXIS; ANDROSTANOLS; ANESTHESIA; HUMANS; PHARMACEUTICAL PREPARATIONS; UNITED STATES; VECURONIUM BROMIDE;

EID: 33846450263     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000253671.90500.0b     Document Type: Letter

References (16)

1. Bhananker SM, O'Donnell JT, Salemi JR, Bishop MJ. The risk of anaphylactic reactions to rocuronium in the United States is comparable to that of vecuronium: an analysis of food and drug administration reporting of adverse events. Anesth Analg 2005;101:819-22.
2. Laxenaire MC. Epidemiology of anesthetic anaphylactoid reactions. Fourth multicenter survey (July 1994-December 1996). Ann Fr Anesth Reanim 1999;18:796-809.
3. Harboe T, Guttormsen AB, Irgens A, et al. Anaphylaxis during anesthesia in Norway: a 6-year single-center follow-up study. Anesthesiology 2005;102:897-903.
4. Fisher MM, Doig GS. Prevention of anaphylactic reactions to anaesthetic drugs. Drug Safety 2004;27:393-410.
5. Mertes PM, Laxenaire MC, Lienhart A, et al. Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice. J Investig Allergol Clin Immunol 2005;15:91-101.
6. Garvey LH, Roed-Petersen J, Menne T, Husum B. Danish Anaesthesia Allergy Centre - preliminary results. Acta Anaesthesiol Scand 2001;45:1204-9.
7. Fisher MM, Baldo BA. The incidence and clinical features of anaphylactic reactions during anesthesia in Australia. Ann Fr Anesth Reanim 1993;12:97-104.
8. Watkins J. Adverse reaction to neuromuscular blockers: frequency, investigation, and epidemiology. Acta Anaesthesiol Scand Suppl 1994;102:6-10.
9. Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003;99:536-45.
10. Rose M, Fisher M. Rocuronium: high risk for anaphylaxis? Br J Anaesth 2001;86:678-82.
11. Guttormsen AB. Allergic reactions during anaesthesia - increased attention to the problem in Denmark and Norway. Acta Anaesthesiol Scand 2001;45:1189-90.
12. Laxenaire MC, Mertes PM. Anaphylaxis during anaesthesia. Results of a two-year survey in France. Br J Anaesth 2001;87:549-58.
13. Tsong Y. Comparing reporting rates of adverse events between drugs with adjustment for year of marketing and secular trends in total reporting. J Biopharm Stat 1995;5:95-114.
14. Trechot P. Pharmacovigilance of anaphylactic shock from anesthetics over a 6 year period (from January 1994 to December 1999). Ann Fr Anesth Reanim 2002;21:34s-37s.
15. Kroigaard M, Garvey LH, Menne T, Husum B. Allergic reactions in anaesthesia: are suspected causes confirmed on subsequent testing? Br J Anaesth 2005;95:468-71.
16. Florvaag E, Johansson SG, Oman H, et al. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol Scand 2005;49:437-44.